3 Results for "

LL-K8-22

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "LL-K8-22" in MCE Product Catalog:

Cat. No.: HY-149209
CAS No.: 3034487-84-5
Purity:  99.76%
Research Areas:  

Metabolic Disease Cancer

LL-K8-22 is a dual degrader of CDK8 and cyclin C HyT, with DC50 values of 2.52 μM and 2.64 μM, respectively. LL-K8-22 inhibits phosphorylation of STAT1 Ser 727, phosphorylation of the C-terminal domain Ser 2/5 of RNA polymerase II, and phosphorylation of Rb. LL-K8-22 represses E2F- and MYC-driven transcriptional programs and exhibits antiproliferative effects. LL-K8-22 synchronously induces proteasome-dependent selective degradation of CDK8 and cyclin C without degrading CDK19, other CDK family members, or other cyclins. LL-K8-22 can be used in the research of triple-negative breast cancer and colon cancer .
loading...
    loading...
Cat. No.: HY-168683
CAS No.: 2924557-38-8
Research Areas:  

Cancer

CDK8 ligand 1 is the ligand of CDK8. CDK8 ligand 1 can be used to synthesize LL-K8-22 (HY-149209) .
loading...
    loading...
Cat. No.: HY-168682
CAS No.: 31685-38-8
Research Areas:  

Cancer

Adamantane-Butyl alcohol is a selective and persistent degrader targeting the CDK8-cyclin C complex. Adamantane-Butyl alcohol is the linker for LL-K8-22 (PROTAC CDK8-cyclin C, HY-149209) and HyT .
loading...
    loading...